DEERFIELD, IL--(Marketwired - Aug 7, 2014) - Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company’s business and announced financial results for the second quarter ended June 30, 2014.
Quarterly Financial Highlights
•Total net sales of $66.1 million versus $11.1 million in second quarter of 2013
•Adjusted EBITDA of $23.8 million
• Adjusted non-GAAP net income of $20.7 million, or $0.21 non-GAAP diluted earnings per share
• Cash and cash equivalents of $128.9 million at June 30, 2014
Help employers find you! Check out all the jobs and post your resume.
